Neurovascular Embolization Devices Market Size, Share, and Trends 2026 to 2035

Neurovascular Embolization Devices Market (By Device Type: Coils, Flow Diverters & Stents, Liquid Embolic Agents, Detachable Balloons, Other Embolization Devices; By Technology/Material: Metallic/Coils, Polymer-based Flow Diverters, Liquid Polymer Embolics, Bioresorbable/Hybrid Materials; By Application: Cerebral Aneurysms, Arteriovenous Malformations (AVMs), Dural Arteriovenous Fistulas (DAVFs), Tumor Embolization, Other Neurovascular Conditions; By End User: Hospitals & Specialty Neuro Clinics, Ambulatory Surgical Centers, Diagnostic & Imaging Centers, Other End Users) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035

Last Updated : 18 Feb 2026  |  Report Code : 7749  |  Category : Healthcare   |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Neurovascular Embolization Devices Market 

5.1. COVID-19 Landscape: Neurovascular Embolization Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Neurovascular Embolization Devices Market, By Device Type

8.1. Neurovascular Embolization Devices Market Revenue and Volume Forecast, by Device Type

8.1.1. Coils

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Flow Diverters & Stents

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Liquid Embolic Agents

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Detachable Balloons

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Other Embolization Devices

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global Neurovascular Embolization Devices Market, By Technology/Material

9.1. Neurovascular Embolization Devices Market Revenue and Volume Forecast, by Technology/Material

9.1.1. Metallic/Coils 

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Polymer-based Flow Diverters 

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Liquid Polymer Embolics 

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Bioresorbable/Hybrid Materials

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global Neurovascular Embolization Devices Market, By Application

10.1. Neurovascular Embolization Devices Market Revenue and Volume Forecast, by ApplicationCerebral Aneurysms

10.1.1. Cerebral Aneurysms 

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Arteriovenous Malformations (AVMs) 

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Dural Arteriovenous Fistulas (DAVFs) 

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Tumor Embolization 

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Other Neurovascular Conditions

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Neurovascular Embolization Devices Market, By End User

11.1. Neurovascular Embolization Devices Market Revenue and Volume Forecast, by End User

11.1.1. Hospitals & Specialty Neuro Clinics 

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Ambulatory Surgical Centers 

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Diagnostic & Imaging Centers 

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Other End Users 

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global Neurovascular Embolization Devices Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Device Type

12.1.2. Market Revenue and Volume Forecast, by Technology/Material

12.1.3. Market Revenue and Volume Forecast, by Application

12.1.4. Market Revenue and Volume Forecast, by End User

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Device Type

12.1.5.2. Market Revenue and Volume Forecast, by Technology/Material

12.1.5.3. Market Revenue and Volume Forecast, by Application

12.1.5.4. Market Revenue and Volume Forecast, by End User

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Device Type

12.1.6.2. Market Revenue and Volume Forecast, by Technology/Material

12.1.6.3. Market Revenue and Volume Forecast, by Application

12.1.6.4. Market Revenue and Volume Forecast, by End User

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Device Type

12.2.2. Market Revenue and Volume Forecast, by Technology/Material

12.2.3. Market Revenue and Volume Forecast, by Application

12.2.4. Market Revenue and Volume Forecast, by End User

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Device Type

12.2.5.2. Market Revenue and Volume Forecast, by Technology/Material

12.2.5.3. Market Revenue and Volume Forecast, by Application

12.2.5.4. Market Revenue and Volume Forecast, by End User

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Device Type

12.2.6.2. Market Revenue and Volume Forecast, by Technology/Material

12.2.6.3. Market Revenue and Volume Forecast, by Application

12.2.6.4. Market Revenue and Volume Forecast, by End User

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Device Type

12.2.7.2. Market Revenue and Volume Forecast, by Technology/Material

12.2.7.3. Market Revenue and Volume Forecast, by Application

12.2.7.4. Market Revenue and Volume Forecast, by End User

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Device Type

12.2.8.2. Market Revenue and Volume Forecast, by Technology/Material

12.2.8.3. Market Revenue and Volume Forecast, by Application

12.2.8.4. Market Revenue and Volume Forecast, by End User

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Device Type

12.3.2. Market Revenue and Volume Forecast, by Technology/Material

12.3.3. Market Revenue and Volume Forecast, by Application

12.3.4. Market Revenue and Volume Forecast, by End User

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Device Type

12.3.5.2. Market Revenue and Volume Forecast, by Technology/Material

12.3.5.3. Market Revenue and Volume Forecast, by Application  

12.3.5.4. Market Revenue and Volume Forecast, by End User

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Device Type

12.3.6.2. Market Revenue and Volume Forecast, by Technology/Material

12.3.6.3. Market Revenue and Volume Forecast, by Application

12.3.6.4. Market Revenue and Volume Forecast, by End User

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Device Type

12.3.7.2. Market Revenue and Volume Forecast, by Technology/Material

12.3.7.3. Market Revenue and Volume Forecast, by Application

12.3.7.4. Market Revenue and Volume Forecast, by End User

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Device Type

12.3.8.2. Market Revenue and Volume Forecast, by Technology/Material

12.3.8.3. Market Revenue and Volume Forecast, by Application

12.3.8.4. Market Revenue and Volume Forecast, by End User

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Device Type

12.4.2. Market Revenue and Volume Forecast, by Technology/Material

12.4.3. Market Revenue and Volume Forecast, by Application

12.4.4. Market Revenue and Volume Forecast, by End User

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Device Type

12.4.5.2. Market Revenue and Volume Forecast, by Technology/Material

12.4.5.3. Market Revenue and Volume Forecast, by Application

12.4.5.4. Market Revenue and Volume Forecast, by End User

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Device Type

12.4.6.2. Market Revenue and Volume Forecast, by Technology/Material

12.4.6.3. Market Revenue and Volume Forecast, by Application

12.4.6.4. Market Revenue and Volume Forecast, by End User

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Device Type

12.4.7.2. Market Revenue and Volume Forecast, by Technology/Material

12.4.7.3. Market Revenue and Volume Forecast, by Application

12.4.7.4. Market Revenue and Volume Forecast, by End User

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Device Type

12.4.8.2. Market Revenue and Volume Forecast, by Technology/Material

12.4.8.3. Market Revenue and Volume Forecast, by Application

12.4.8.4. Market Revenue and Volume Forecast, by End User

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Device Type

12.5.2. Market Revenue and Volume Forecast, by Technology/Material

12.5.3. Market Revenue and Volume Forecast, by Application

12.5.4. Market Revenue and Volume Forecast, by End User

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Device Type

12.5.5.2. Market Revenue and Volume Forecast, by Technology/Material

12.5.5.3. Market Revenue and Volume Forecast, by Application

12.5.5.4. Market Revenue and Volume Forecast, by End User

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Device Type

12.5.6.2. Market Revenue and Volume Forecast, by Technology/Material

12.5.6.3. Market Revenue and Volume Forecast, by Application

12.5.6.4. Market Revenue and Volume Forecast, by End User

Chapter 13. Company Profiles

13.1. Johnson & Johnson Services, Inc. (CERENOVUS) 

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Terumo Corporation (MicroVention, Inc.)

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Acandis GmbH 

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Balt Group (Balt SAS)

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. MicroPort Scientific Corporation 

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. phenox GmbH 

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Rapid Medical 

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Perflow Medical Ltd.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. ASAHI INTECC CO., LTD. 

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Imperative Care

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The neurovascular embolization devices market size is expected to increase from USD 1.5 billion in 2025 to USD 4.58 billion by 2035.

Answer : The neurovascular embolization devices market is expected to grow at a compound annual growth rate (CAGR) of around 11.80% from 2026 to 2035.

Answer : The driving factors of the neurovascular embolization devices market are driven by the rising prevalence of neurological disorders, advancements in medical technologies, and evolving regulatory landscapes.

Answer : North America region will lead the global neurovascular embolization devices market during the forecast period 2026 to 2035.

Answer : The major players in the neurovascular embolization devices market include Stryker Corporation, Medtronic plc, Penumbra, Inc., Johnson & Johnson Services, Inc. (CERENOVUS) , Terumo Corporation (MicroVention, Inc.), Acandis GmbH , Balt Group (Balt SAS), MicroPort Scientific Corporation, phenox GmbH, Rapid Medical, Perflow Medical Ltd., ASAHI INTECC CO., LTD. , and Imperative Care

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client